ERK inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9469652
APP PUB NO 20160176896A1
SERIAL NO

14970588

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides thieno[2,3-c]pyrrol-4-one compounds that inhibit activity of extracellular-signal-regulated kinase (ERK) and may be useful in the treatment of cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • ELI LILLY AND COMPANY

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cortez, Guillermo S Indianapolis, US 10 7
Joseph, Sajan Carmel, US 29 233
McLean, Johnathan Alexander Indianapolis, US 13 15
McMillen, William T McCordsville, US 5 15
Rodriguez, Michael John Indianapolis, US 11 48
Zhao, Gaiying Carmel, US 9 27

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 18, 2024
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 18, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00